<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03112863</url>
  </required_header>
  <id_info>
    <org_study_id>1015536</org_study_id>
    <nct_id>NCT03112863</nct_id>
  </id_info>
  <brief_title>Comparison of the Cosmetic Effects of Bakuchiol and Retinol</brief_title>
  <official_title>Comparison of the Cosmetic Effects of Bakuchiol and Retinol</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, Davis</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of California, Davis</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Subjects will be assigned to a retinoid cream or bakuchiol to compare the cosmetic effects.
      This will take place over a 12 week period.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 24, 2017</start_date>
  <completion_date type="Anticipated">March 2027</completion_date>
  <primary_completion_date type="Anticipated">March 2027</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Double blind randomized study comparing the effect of bakuchiol and retinoid</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in wrinkle appearance</measure>
    <time_frame>12 week</time_frame>
    <description>Assessed using image analysis based assessment of wrinkle severity (depth and length)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in appearance of skin pigmentation</measure>
    <time_frame>12 week</time_frame>
    <description>Assessed using image analysis based assessment of facial pigment</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Subjective Tolerability Assessment</measure>
    <time_frame>Assessed at Week 4, 8, and 12.</time_frame>
    <description>Subjective tolerability assessment of stinging, burning, itching</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Facial Erythema Assessment</measure>
    <time_frame>week 4, week 8 and week 12</time_frame>
    <description>Image analysis based assessment of facial erythema</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in appearance of skin pigmentation</measure>
    <time_frame>week 4 and week 8</time_frame>
    <description>Assessed using image analysis based assessment of facial pigment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in wrinkle appearance</measure>
    <time_frame>week 4 and week 8</time_frame>
    <description>Assessed using image analysis based assessment of wrinkle severity (depth and length)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical assessment of facial redness</measure>
    <time_frame>week 0, week 4, week 8, and week 12</time_frame>
    <description>dermatologist based assessment of redness at each visit based on Likert scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical assessment of facial scaling</measure>
    <time_frame>week 0, week 4, week 8, and week 12</time_frame>
    <description>dermatologist based assessment of scaling at each visit based on Likert scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical assessment of facial hyperpigmentation</measure>
    <time_frame>week 0, week 4, week 8, and week 12</time_frame>
    <description>dermatologist based assessment of facial hyperpigmentation at each visit based on Likert scale</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Wrinkle</condition>
  <condition>Photoaging</condition>
  <arm_group>
    <arm_group_label>Bakuchiol</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Retinol</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bakuchiol</intervention_name>
    <description>This group will receive bakuchiol</description>
    <arm_group_label>Bakuchiol</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Retinol</intervention_name>
    <description>This group will receive retinol</description>
    <arm_group_label>Retinol</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        â€¢ Individuals aged 30-55

        Exclusion Criteria:

          -  Adults unable to consent

          -  Individuals who are not yet adults (infants, children, teenagers)

          -  Pregnant or breast feeding women

          -  Prisoners

          -  Those with acne, eczema, seborrheic dermatitis, rosacea or polycystic ovarian syndrome

          -  Those who have used isotretinoin in the last 6 months

          -  Those who have used products containing salicylic acid, beta hydroxyl acids or
             vitamins A, C, or E in the last 14 days

          -  Those who have used topical antibiotics or topical retinoids in the last 30 days

          -  Those who are currently smoking or have smoked within the past 3 years.

          -  Those who have had a recent surgical or cosmetic procedure in the last 3 months that
             can affect facial wrinkles or facial hyperpigmentation, such as botulinum toxin
             injections, chemical peels, laser based therapies to the face, or face lift surgeries
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Raja Sivamani, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>UC Davis</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Manisha Notay, MBBS</last_name>
    <phone>9167346550</phone>
    <email>mnotay@ucdavis.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>UC Davis Department of Dermatology</name>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <zip>95816</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Manisha Notay, MBBS</last_name>
      <phone>916-734-6550</phone>
      <email>mnotay@ucdavis.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 27, 2017</study_first_submitted>
  <study_first_submitted_qc>April 7, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 13, 2017</study_first_posted>
  <last_update_submitted>May 21, 2018</last_update_submitted>
  <last_update_submitted_qc>May 21, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 23, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamin A</mesh_term>
    <mesh_term>Retinol palmitate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

